Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Methodist Texsan Hospital
mi
from
San Antonio, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Methodist Texsan Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Trinity Mother Frances Health System
mi
from
Tyler, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Trinity Mother Frances Health System
mi
from
Tyler, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Lynchburg General Hospital
mi
from
Lynchburg, VA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Lynchburg General Hospital
mi
from
Lynchburg, VA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Deaconess Medical Center
mi
from
Spokane, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Deaconess Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Health and Services - Washington
mi
from
Spokane, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Health and Services - Washington
mi
from
Spokane, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Aspirus Heart and Vascular Institute - Research and Education
mi
from
Wausau, WI
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Aspirus Heart and Vascular Institute - Research and Education
mi
from
Wausau, WI
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Monash Medical Centre
mi
from
Clayton,
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Monash Medical Centre
mi
from
Clayton,
Click here to add this to my saved trials
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
Status: Enrolling
Updated:  12/31/1969
Upstate Hospital Emergency Department
mi
from
Syracuse, NY
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
Status: Enrolling
Updated: 12/31/1969
Upstate Hospital Emergency Department
mi
from
Syracuse, NY
Click here to add this to my saved trials
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
Giant Cell Myocarditis Treatment Trial Pilot Study
Status: Enrolling
Updated:  6/23/2005
Mayo Clinic Rochester
mi
from
Rochester, MN
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
Giant Cell Myocarditis Treatment Trial Pilot Study
Status: Enrolling
Updated: 6/23/2005
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated:  6/23/2005
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated: 6/23/2005
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
Status: Enrolling
Updated:  6/23/2005
Indiana University School of Medicine
mi
from
Indianapolis, IN
Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
Status: Enrolling
Updated: 6/23/2005
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Status: Enrolling
Updated:  9/14/2005
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Status: Enrolling
Updated: 9/14/2005
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Status: Enrolling
Updated:  9/14/2005
Emory University Hospital
mi
from
Atlanta, GA
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Status: Enrolling
Updated: 9/14/2005
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Bioheart, Inc
mi
from
Ft. Lauderdale, FL
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Bioheart, Inc
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
ACRI
mi
from
Atlanta, GA
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
ACRI
mi
from
Atlanta, GA
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Mt. Sinai Medical Center
mi
from
New York, NY
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Duke University
mi
from
Durham, NC
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
Pregnancy Related Cardiomyopathy Enrollment and Lessons in Web-Based Recruitment (PRiCELESS)
Status: Enrolling
Updated:  5/25/2006
Saint Vincent's Catholic Medical Center
mi
from
New York, NY
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
Pregnancy Related Cardiomyopathy Enrollment and Lessons in Web-Based Recruitment (PRiCELESS)
Status: Enrolling
Updated: 5/25/2006
Saint Vincent's Catholic Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Cedar Sinai Department of Cardiothoracic Surgery
mi
from
Los Angeles, CA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Cedar Sinai Department of Cardiothoracic Surgery
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
St. Joseph's Hospital
mi
from
St. Petersburg, FL
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
St. Joseph's Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Emory University
mi
from
Atlanta, GA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Maryland College of Medicine
mi
from
Baltimore, MD
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Maryland College of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Massachusetts
mi
from
Worcester, MA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Michigan
mi
from
Ann Arbor, MI
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
NYU College of Medicine
mi
from
New York, NY
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
NYU College of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Drexel University College of Medicine
mi
from
Philadelphia, PA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Virginia College of Medicine
mi
from
Charlottesville, VA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Virginia College of Medicine
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The Effects of Case Management in a Medicaid Managed Care Plan
The Effects of Case Management in a Medicaid Managed Care Plan
Status: Enrolling
Updated:  10/10/2006
Metropolitan Jewish Health System
mi
from
Brooklyn, NY
The Effects of Case Management in a Medicaid Managed Care Plan
The Effects of Case Management in a Medicaid Managed Care Plan
Status: Enrolling
Updated: 10/10/2006
Metropolitan Jewish Health System
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Assessment of Translesional Markers and Metabolomics
An Assessment of Translesional Markers and Metabolomics
Status: Enrolling
Updated:  11/1/2006
Emory University Hospital
mi
from
Atlanta, GA
Assessment of Translesional Markers and Metabolomics
An Assessment of Translesional Markers and Metabolomics
Status: Enrolling
Updated: 11/1/2006
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  12/1/2006
Children's Hospital and Research Center
mi
from
Oakland, CA
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 12/1/2006
Children's Hospital and Research Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  12/1/2006
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 12/1/2006
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  12/1/2006
Duke University
mi
from
Durham, NC
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 12/1/2006
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  12/1/2006
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 12/1/2006
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion. A Prospective Randomized Trial Comparing Silverhawk™ Atherectomy to CryoPlasty® Therapy for Lower Extremity Claudication
Status: Enrolling
Updated:  12/4/2006
University of California, San Diego Medical Center, Hillcrest
mi
from
San Diego, CA
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion. A Prospective Randomized Trial Comparing Silverhawk™ Atherectomy to CryoPlasty® Therapy for Lower Extremity Claudication
Status: Enrolling
Updated: 12/4/2006
University of California, San Diego Medical Center, Hillcrest
mi
from
San Diego, CA
Click here to add this to my saved trials
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease
Status: Enrolling
Updated:  3/6/2007
Memorial Hermann Hospital
mi
from
Houston, TX
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease
Status: Enrolling
Updated: 3/6/2007
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
BNP Therapy Observation Unit Outcomes STudy (BOOST)
BNP Therapy Observation Unit Outcomes STudy
Status: Enrolling
Updated:  3/28/2007
Grady Memorial Hospital
mi
from
Atlanta, GA
BNP Therapy Observation Unit Outcomes STudy (BOOST)
BNP Therapy Observation Unit Outcomes STudy
Status: Enrolling
Updated: 3/28/2007
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
St. Francis Hospital
mi
from
Roslyn, NY
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Stony Brook University Medical Center
mi
from
Stony Brook, NY
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Baylor College of Medicine
mi
from
Houston, TX
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Swedish Medical Center
mi
from
Seattle, WA
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated:  7/18/2007
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated: 7/18/2007
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated:  7/18/2007
Manhattan Eye, Ear & Throat Hospital
mi
from
New York, NY
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated: 7/18/2007
Manhattan Eye, Ear & Throat Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Retrospective Study of the Impact of Drug Eluting Stents
Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
Status: Enrolling
Updated:  8/1/2007
Sacred Heart Medical Center
mi
from
Spokane, WA
Retrospective Study of the Impact of Drug Eluting Stents
Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
Status: Enrolling
Updated: 8/1/2007
Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials